Sponsor Pipeline

Cellectar Biosciences, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
1
Phase 3
7
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-14 NCT07766421 Evaluation of Iopofosine I 131 vs. R-CD in WM Patients Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07766421 Evaluation of Iopofosine I 131 vs. R-CD in WM Patients Waldenstrom Macroglobulinaemia Not Yet Recruiting
Phase 2
NCT02952508 Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With… Waldenstrom Macroglobulinemia Active, Not Recruiting
Phase 1
NCT07311993 Phase 1 Study of CLR 125 in Triple Negative Breast Cancer Breast Cancer Recruiting
NCT03478462 Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors… Pediatric Solid Tumor Active, Not Recruiting
NCT05610891 Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory… High-Grade Glioma Active, Not Recruiting
Disease Areas
Leukemia (1) Chronic Lymphocytic Leukemia (CLL) (1) Multiple Myeloma (1) Mantle Cell Lymphoma (1) Sarcoma (1) Glioma (1) Breast Cancer (1)
Get alerts when Cellectar Biosciences, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free